Showing 1 - 8 results of 8 for search 'J. Nahas', query time: 0.03s Refine Results
  1. 1
    The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review

    The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review by Jessica Ailani, Stephanie J. Nahas, Deborah I. Friedman, Todd Kunkel

    Published 2023-04-01
    Get full text
    Article
  2. 2
    Two-Dimensional Heterojunction Interlayer Tunneling Field Effect Transistors (Thin-TFETs)

    Two-Dimensional Heterojunction Interlayer Tunneling Field Effect Transistors (Thin-TFETs) by Mingda Oscar Li, David Esseni, Joseph J. Nahas, Debdeep Jena, Huili Grace Xing

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine

    Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine by Stephanie J. Nahas, Nada Hindiyeh, Deborah I. Friedman, Nada Elbuluk, Donald J. Kellerman, Pamela K. Foreman, Peter Schmidt

    Published 2021-05-01
    Get full text
    Article
  4. 4
    Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study

    Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study by Larry Charleston, Brian Talon, Christine Sullivan, Carlton Anderson, Steven Kymes, Stephane A. Regnier, Seema Soni-Brahmbhatt, Stephanie J. Nahas

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

    Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, pla... by Stephanie J. Nahas, Steffen Naegel, Joshua M. Cohen, Xiaoping Ning, Lindsay Janka, Verena Ramirez Campos, Lynda J. Krasenbaum, Dagny Holle-Lee, David Kudrow, Christian Lampl

    Published 2022-05-01
    Get full text
    Article
  6. 6
    Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

    Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-control... by Stephanie J. Nahas, Steffen Naegel, Joshua M. Cohen, Xiaoping Ning, Lindsay Janka, Verena Ramirez Campos, Lynda J. Krasenbaum, Dagny Holle-Lee, David Kudrow, Christian Lampl

    Published 2021-11-01
    Get full text
    Article
  7. 7
    Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials

    Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials by Paul Rizzoli, Michael J. Marmura, Jennifer Robblee, Jennifer McVige, Sara Sacco, Stephanie J. Nahas, Jessica Ailani, Rosa De Abreu Ferreira, Julia Ma, Jonathan H. Smith, Brett Dabruzzo, Messoud Ashina

    Published 2024-03-01
    Get full text
    Article
  8. 8
    Obesity in acute alcoholic hepatitis increases morbidity and mortalityResearch in context

    Obesity in acute alcoholic hepatitis increases morbidity and mortalityResearch in context by Richard Parker, S.J. Kim, G.Y. Im, J. Nahas, B. Dhesi, N. Vergis, A. Sinha, A. Ghezzi, M.R. Rink, A. McCune, G.P. Aithal, P.N. Newsome, C.J. Weston, A. Holt, B. Gao

    Published 2019-07-01
    Get full text
    Article

Search Tools: